← All trials
NCT01188499
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2010
- Primary completion
- Oct 1, 2013
- Completion date
- Mar 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 176
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- TetraLogic PharmaceuticalsLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- Mary Crowley Cancer CenterOverall official - principal investigator
- South Texas Accelerated Research TherapeuticsOverall official - principal investigator
- Wayne State UniversityOverall official - principal investigator
- Temple UniversityOverall official - principal investigator
- State University of New York, BuffaloOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.